METHODS	Tolerability and pharmacokinetics of current GMP intravenous AS , as an anti-malarial agent , were evaluated after ascending multiple doses of 2 , 4 , and 8 mg/kg daily for three days with 2-minute infusion in 24 healthy subjects ( divided into three groups ) in the Phase 1 clinical trial study .\